Literature DB >> 25631636

Damage control resuscitation.

Timothy H Pohlman1, Mark Walsh2, John Aversa2, Emily M Hutchison3, Kristen P Olsen4, R Lawrence Reed5.   

Abstract

The early recognition and management of hemorrhage shock are among the most difficult tasks challenging the clinician during primary assessment of the acutely bleeding patient. Often with little time, within a chaotic setting, and without sufficient clinical data, a decision must be reached to begin transfusion of blood components in massive amounts. The practice of massive transfusion has advanced considerably and is now a more complete and, arguably, more effective process. This new therapeutic paradigm, referred to as damage control resuscitation (DCR), differs considerably in many important respects from previous management strategies for catastrophic blood loss. We review several important elements of DCR including immediate correction of specific coagulopathies induced by hemorrhage and management of several extreme homeostatic imbalances that may appear in the aftermath of resuscitation. We also emphasize that the foremost objective in managing exsanguinating hemorrhage is always expedient and definitive control of the source of bleeding.
Copyright © 2015. Published by Elsevier Ltd.

Entities:  

Keywords:  Complications of transfusion; Damage control resuscitation; Hemorrhage-associated coagulopathy; Hemorrhagic shock; Hemostatic resuscitation

Mesh:

Year:  2015        PMID: 25631636     DOI: 10.1016/j.blre.2014.12.006

Source DB:  PubMed          Journal:  Blood Rev        ISSN: 0268-960X            Impact factor:   8.250


  7 in total

1.  Cardiac arrest due to massive hemorrhage from uterine adenomyosis with leiomyoma successfully treated with damage control resuscitation.

Authors:  Takeshi Yagi; Motoki Fujita; Tomoaki Inoue; Mari Otsuji; Yasutaka Koga; Takashi Nakahara; Takashi Miyauchi; Kotaro Kaneda; Yasutaka Oda; Ryosuke Tsuruta
Journal:  Acute Med Surg       Date:  2016-04-18

2.  2017 Military Supplement: Hemoglobin-based Oxygen Carriers: Current State-of-the-Art and Novel Molecules.

Authors:  Anirban Sen Gupta
Journal:  Shock       Date:  2017-09-29       Impact factor: 3.454

Review 3.  Biomaterials and Advanced Technologies for Hemostatic Management of Bleeding.

Authors:  DaShawn A Hickman; Christa L Pawlowski; Ujjal D S Sekhon; Joyann Marks; Anirban Sen Gupta
Journal:  Adv Mater       Date:  2017-11-22       Impact factor: 30.849

4.  Massive transfusion prediction in patients with multiple trauma by decision tree: a retrospective analysis.

Authors:  Liu Wei; Wu Chenggao; Zou Juan; Le Aiping
Journal:  Indian J Hematol Blood Transfus       Date:  2020-09-12       Impact factor: 0.900

Review 5.  Optimizing transfusion strategies in damage control resuscitation: current insights.

Authors:  Timothy H Pohlman; Alison M Fecher; Cecivon Arreola-Garcia
Journal:  J Blood Med       Date:  2018-08-20

Review 6.  Massive transfusion triggers in severe trauma: Scoping review.

Authors:  Cristina Estebaranz-Santamaría; Ana María Palmar-Santos; Azucena Pedraz-Marcos
Journal:  Rev Lat Am Enfermagem       Date:  2018-11-29

7.  Benefits of Initial Limited Crystalloid Resuscitation in Severely Injured Trauma Patients at Emergency Department.

Authors:  Hao Wang; Richard D Robinson; Jessica Laureano Phillips; Alexander J Kirk; Therese M Duane; Johnbosco Umejiego; Melanie Stanzer; Mackenzie B Campbell-Furtick; Nestor R Zenarosa
Journal:  J Clin Med Res       Date:  2015-10-23
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.